Charles-Henri Hassan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Charles-Henri Hassan has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
A. Moya-Plana
1 shared publicationA.-C. Baglin
1 shared publicationAndré Coste
Service d'ORL et de chirurgie cervico‐faciale, Centre Hospitalier Intercommunal de Créteil France
1 shared publicationB. Vérillaud
1 shared publication- Bertrand Baujat
Sorbonne University, APHP, Department of ENT-Head and Neck Surgery, Tenon Hospital, 4 rue de la chine, 75020, Paris, France
1 shared publication C. Even
1 shared publication
Latest Publications
- 15 April 2026
- Published by Elsevier in Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale
- Vol. 143 (2) , 116-122
Recommandations de bonnes pratiques REFCOR pour le traitement des cancers des sinus et des fosses nasales
- 15 April 2026
- Published by Elsevier in Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale
- Vol. 143 (2) , 116-122
Recommandations de bonnes pratiques REFCOR pour le traitement des cancers des sinus et des fosses nasales
- 5 July 2023
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 44 (6) , 103974
Outpatient parotidectomy: Outcomes, safety and satisfaction
- 5 July 2023
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 44 (6) , 103974
Outpatient parotidectomy: Outcomes, safety and satisfaction
- Open Access
- 8 December 2021
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 7 (1) , 6-11
Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique
Objectives: Atrophic rhinitis (AR) and empty nose syndrome (ENS) are chronic diseases characterized by a paradoxical nasal obstruction. These rare syndromes tend to occur after nasal surgery of the inferior turbinates in ENS and can be idiopathic in AR. Medical treatments alone are often insufficient. Surgical options are challenging and numerous resorbable and nonresorbable implants have been described in small series, with as many surgical techniques described. Whereas current surgical procedures are for risk of extrusions, graft rejections or poor lasting results, the use of GlassBONE™ (Sodimed®, Avignon, France), a bioactive glass, for a vestibular approach in AR and ENS has never been reported for this indication.Methods: We described an original technique of nasal submucoperiosteal bilateral ceramic glass implantation in two patients with AR and ENS.Results: The two cases presented a postoperative satisfying endoscopic and sinus CT‐scan results with filling of the nasal cavities, with less crusts and a complete wound healing. They had no short‐term complications.Conclusion: This innovative approach is easily feasible and could be an option considered for the surgical management of AR and ENS.Level of evidence: 4.
- 8 December 2021
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 7 (1) , 6-11
Open AccessSublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique
Objectives: Atrophic rhinitis (AR) and empty nose syndrome (ENS) are chronic diseases characterized by a paradoxical nasal obstruction. These rare syndromes tend to occur after nasal surgery of the inferior turbinates in ENS and can be idiopathic in AR. Medical treatments alone are often insufficient. Surgical options are challenging and numerous resorbable and nonresorbable implants have been described in small series, with as many surgical techniques described. Whereas current surgical procedures are for risk of extrusions, graft rejections or poor lasting results, the use of GlassBONE™ (Sodimed®, Avignon, France), a bioactive glass, for a vestibular approach in AR and ENS has never been reported for this indication.Methods: We described an original technique of nasal submucoperiosteal bilateral ceramic glass implantation in two patients with AR and ENS.Results: The two cases presented a postoperative satisfying endoscopic and sinus CT‐scan results with filling of the nasal cavities, with less crusts and a complete wound healing. They had no short‐term complications.Conclusion: This innovative approach is easily feasible and could be an option considered for the surgical management of AR and ENS.Level of evidence: 4.